These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 14640928

  • 1. Palonosetron: a unique 5-HT3-receptor antagonist for the prevention of chemotherapy-induced emesis.
    Grunberg SM, Koeller JM.
    Expert Opin Pharmacother; 2003 Dec; 4(12):2297-303. PubMed ID: 14640928
    [Abstract] [Full Text] [Related]

  • 2. Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.
    Rubenstein EB.
    Clin Adv Hematol Oncol; 2004 May; 2(5):284-9. PubMed ID: 16163194
    [Abstract] [Full Text] [Related]

  • 3. Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results of a phase III, single-dose trial versus dolasetron.
    Eisenberg P, Figueroa-Vadillo J, Zamora R, Charu V, Hajdenberg J, Cartmell A, Macciocchi A, Grunberg S, 99-04 Palonosetron Study Group.
    Cancer; 2003 Dec 01; 98(11):2473-82. PubMed ID: 14635083
    [Abstract] [Full Text] [Related]

  • 4. Serotonin receptor antagonists for highly emetogenic chemotherapy in adults.
    Billio A, Morello E, Clarke MJ.
    Cochrane Database Syst Rev; 2010 Jan 20; (1):CD006272. PubMed ID: 20091591
    [Abstract] [Full Text] [Related]

  • 5. Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron.
    Gralla R, Lichinitser M, Van Der Vegt S, Sleeboom H, Mezger J, Peschel C, Tonini G, Labianca R, Macciocchi A, Aapro M.
    Ann Oncol; 2003 Oct 20; 14(10):1570-7. PubMed ID: 14504060
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative efficacy and safety of palonosetron with the first 5-HT3 receptor antagonists for the chemotherapy-induced nausea and vomiting: a meta-analysis.
    Jin Y, Sun W, Gu D, Yang J, Xu Z, Chen J.
    Eur J Cancer Care (Engl); 2013 Jan 20; 22(1):41-50. PubMed ID: 22519361
    [Abstract] [Full Text] [Related]

  • 10. Palonosetron: in the prevention of nausea and vomiting.
    Yang LP, Scott LJ.
    Drugs; 2009 Nov 12; 69(16):2257-78. PubMed ID: 19852528
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Palonosetron for the treatment of chemotherapy-induced nausea and vomiting.
    Navari RM.
    Expert Opin Pharmacother; 2014 Dec 12; 15(17):2599-608. PubMed ID: 25323946
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness of palonosetron versus other serotonin 5-HT3 receptor antagonists in triple antiemetic regimens during multiday highly emetogenic chemotherapy.
    Kim KI, Lee DE, Cho I, Yoon JH, Yoon SS, Lee HS, Oh JM.
    Ann Pharmacother; 2012 Dec 12; 46(12):1637-44. PubMed ID: 23170032
    [Abstract] [Full Text] [Related]

  • 15. New antiemetic drugs.
    Roila F, Fatigoni S.
    Ann Oncol; 2006 Mar 12; 17 Suppl 2():ii96-100. PubMed ID: 16608997
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Review of palonosetron: emerging data distinguishing it as a novel 5-HT(3) receptor antagonist for chemotherapy-induced nausea and vomiting.
    Saito M, Tsukuda M.
    Expert Opin Pharmacother; 2010 Apr 12; 11(6):1003-14. PubMed ID: 20307224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.